[Successful treatment for tachyarrhythmia with ultra short acting beta-blocker during beating coronary artery bypass grafting; report of a case].

Abstract

A 62-year-old man with supraventricular/ventricular tachycardia associated with myocardial infarction developed tachycardia during beating coronary artery bypass grafting (CABG). Intravenous administration of an ultra short acting beta-blocker, landiolol hydrochloride, controlled heart rate and improved tachyarrhythmia without significant change of blood pressure. Landiolol hydrochloride is effective and useful for the treatment of tachyarrhythmia during beating CABG.

• Authors: T Shimomura, G Fujii, S Suzuki, K Miyahara, A Matsuura, K Yoshida, M Kasamatsu
• Journal: Kyobu geka. The Japanese journal of thoracic surgery (Kyobu Geka) Vol. 57 Issue 3 Pg. 229-32 (Mar 2004) ISSN: 0021-5252 [Print] Japan
• PMID: 15035081 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Adrenergic beta-Antagonists
• Morpholines
• landiolol
• Urea

Topics

• Adrenergic beta-Antagonists (administration & dosage)
• Coronary Artery Bypass (methods)
• Humans
• Infusions, Intravenous
• Intraoperative Complications (drug therapy)
• Male
• Middle Aged
• Morpholines (administration & dosage)
• Tachycardia (drug therapy)
• Treatment Outcome
• Urea (administration & dosage, analogs & derivatives)